Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors, antagonists |
Mechanism MYD88 inhibitors(MYD88 innate immune signal transduction adaptor inhibitors), TRAF6 antagonists(TNF receptor associated factor 6 antagonists), p38 MAPK inhibitors(P38 mitogen-activated protein kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammatory Bowel Diseases | Preclinical | United States | 19 Sep 2024 |